China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy

HONG KONG, July 23, 2014 /PRNewswire-FirstCall/ — China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, and Cordlife Group Limited ("Cordlife"), a multi-product …

Read More